Is There Any Difference between the In Situ and Systemic IL-10 and IFN-γ Production when Clinical Forms of Cutaneous Sporotrichosis Are Compared?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Fungus of the Sporothrix schenckii complex can produce skin lesions in humans, commonly lymphocutaneous (LC) and fixed (F) forms of sporotrichosis. Some authors have suggested that clinical forms are influenced by differences in virulence and genetic profile of isolates. But little is known about the role of immune response in determining the clinical outcome of sporotrichosis. To verify the profile of systemic and in situ IFN-γ and IL-10 expression in sporotrichosis patients, and consequently to detect any difference between the two compartments and/or clinical presentation, we quantified the number of IFN-γ and IL-10 producer peripheral blood mononuclear cells stimulated with S. schenckii antigen (Ss-Ag) by Elispot, and quantified cytokines expression by in situ immunohistochemistry in the same patient. Three groups were formed: 1- LC (n = 9); 2- F (n = 10); 3- healthy individuals (n = 14). All sporotrichosis patients produced high amounts of systemic IFN- γ when compared to uninfected individuals. No differences were observed between LC and F groups. Regarding in situ IL-10 expression, a difference between LC and F groups was observed: LC lesions presented higher amounts of IL-10 than F lesions differently from systemic IL-10 which showed similarities. Our data suggests that LC lesions present higher IL-10 expression which could be related to regulatory mechanisms for compensating the tissue injury, however favoring fungal persistence in the lesions. Surprisingly, there were no differences in systemic and in situ IFN- γ expression between CL and F patients, although it was significantly higher expressed in these patients than in healthy individuals.

Related collections

Most cited references 38

Record: found
Abstract: found
Article: not found

Immune recognition of Candida albicans beta-glucan by dectin-1.

Steven Bates, S Tsoni, Mihai Netea … (2007)

Beta (1,3)-glucans represent 40% of the cell wall of the yeast Candida albicans. The dectin-1 lectin-like receptor has shown to recognize fungal beta (1,3)-glucans and induce innate immune responses. The importance of beta-glucan-dectin-1 pathways for the recognition of C. albicans by human primary blood cells has not been firmly established. In this study we demonstrate that cytokine production by both human peripheral blood mononuclear cells and murine macrophages is dependent on the recognition of beta-glucans by dectin-1. Heat killing of C. albicans resulted in exposure of beta-glucans on the surface of the cell wall and subsequent recognition by dectin-1, whereas live yeasts stimulated monocytes mainly via recognition of cell-surface mannans. Dectin-1 induced cytokine production through the following 2 pathways: Syk-dependent production of the T-helper (Th) 2-type anti-inflammatory cytokine interleukin-10 and Toll-like receptor-Myd88-dependent stimulation of monocyte-derived proinflammatory cytokines, such as tumor necrosis factor-alpha . In contrast, stimulation of Th1-type cytokines, such as interferon-gamma , by C. albicans was independent of the recognition of beta-glucans by dectin-1. In conclusion, C. albicans induces production of monocyte-derived and T cell-derived cytokines through distinct pathways dependent on or independent of dectin-1.

0 comments Cited 114 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: found

Is Open Access

Sporotrichosis in Rio de Janeiro, Brazil: Sporothrix brasiliensis Is Associated with Atypical Clinical Presentations

Rodrigo Almeida-Paes, Manoel de Oliveira, Dayvison Freitas … (2014)

Introduction Sporotrichosis is a subcutaneous mycosis with a worldwide distribution that is currently notable for areas of especially high endemicity in Latin America [1]–[3]. Some authors classify sporotrichosis as an implantation mycosis, because this infection may also involves other sites beyond the skin and the subcutaneous tissues, such as lymphatic vessels, muscles, fascia, cartilage, and bones [3]. Historically, sporotrichosis has been attributed to a single species, Sporothrix schenckii [1]. However, phenotypic and genotypic analyses by Marimon and coworkers [4] have led to the identification of four new species in the Sporothrix complex: (i) S. globosa, a globally distributed fungus [5]–[7]; (ii) S. brasiliensis, the species related to the zoonotic epidemic of sporotrichosis in Rio de Janeiro, Brazil [8]; (iii) S. mexicana, initially limited to Mexico [4], but with recent cases reported in other regions [9], [10]; and (iv) S. luriei, formerly S. schenckii var. luriei [11]. Classical infection is associated with traumatic subcutaneous inoculation of soil, plants, or organic matter contaminated with fungus, with rare cases of transmission occurring from infected animals [1]. However, in Rio de Janeiro state, Brazil, sporotrichosis is currently largely occurring via transmission from infected cats to humans [12]. Recently, our group performed a georeferencing survey of sporotrichosis cases that revealed a transmission belt along the border between Rio de Janeiro city and adjacent counties in the Greater Metropolitan Area [13]. Genotypic analyses have shown that isolates from the Rio de Janeiro epidemic have a high genetic similarity, which is suggestive of a common niche [14], [15]. Although some studies have described several clinical aspects of this epidemic [12], [16], [17], taxonomic analyses have not been correlated with disease presentations. Therefore, the main purpose of this study was to investigate a possible association between manifestations of sporotrichosis in Rio de Janeiro and the different genomic species of S. schenckii sensu lato. Materials and Methods Ethics Statement This study was approved by the Research Ethics Committee of Fundação Oswaldo Cruz (FIOCRUZ), under the number CAAE-0024.0.009.000-10. All patient samples and data were analyzed anonymously after receiving a random number during database construction. Patients A cross-sectional study was performed in 50 patients with different clinical forms of sporotrichosis. They were selected from a database of 246 patients [8] who had Sporothrix strains isolated from clinical specimens and stored at the Pathogenic Fungal Collection of the Laboratório de Micologia at IPEC, and which were part of a cohort of 1,563 patients with sporotrichosis treated from 1999 to 2008 at the Instituto de Pesquisa Clínica Evandro Chagas (IPEC). Patients were submitted to a protocol that included clinical evaluation, mycological examination of clinical specimens and blood tests (blood count, biochemistry and liver function). In the absence of disseminated disease, oral itraconazole 100 mg/day was prescribed. Higher intraconazole doses were used if the lesions worsened or remained unchanged after eight weeks. The duration of treatment was determined by clinical cure (lesion healing defined as epithelization and absence of crusts, infiltrates, or erythema). Clinical cure of extracutaneous sites was defined as the disappearance of preexisting lesions in cases of conjunctival, nasal, or oral mucosa involvement. Patients with disseminated sporotrichosis received amphotericin B at a total dose of 1–2.5 g. Follow-up was 4–12 weeks after clinical cure. The data were collected by review of medical charts and were recorded on a standardized case report form, containing demographic, epidemiologic, clinical and follow-up information. Since the Rio de Janeiro sporotrichosis outbreak is massive, we had to establish some criteria to select patients related to common and unusual manifestations of sporotrichosis. Inclusion criteria for selection in this study were: patients who lived in Rio de Janeiro city or in other cities from Rio de Janeiro state in Brazil, patients with common (fixed cutaneous and lymphocutaneous) and unusual (disseminated cutaneous, extracutaneous, and disseminated) clinical forms of sporotrichosis [1], patients with and without hypersensitivity manifestations (eythema nodosum or erythema multiforme), patients co-infected with HIV, and patients treated with itraconazole as well as patients with spontaneous regression of lesions. However, for the less common variables (e.g., patients outside the endemic area), all available cases were included. Strains The fungal isolates were cultured from different body sites, such as skin, eyes, nose, or cerebrospinal fluid. Each isolate was previously identified by classical microbiological phenotypic techniques as S. schenckii sensu lato. Additionally, control strains CBS 120339 (S. brasiliensis) [4], ATCC 16345 (S. schenckii), IPEC 27135 (S. globosa) [7], and MUM 11.02 (S. mexicana) [9] were included in identification tests. Phenotypic Characterization Filamentous fungal colonies for each isolate were grown on Sabouraud Dextrose Agar and slide cultures were mounted with Lactophenol Cotton Blue (Fluka Analyted, France) for Sporothrix identification [4]. Dimorphism was demonstrated by conversion to the yeast-like form on Brain Heart Infusion Agar slants for 7 days at 37°C. Furthermore, colonies were sub-cultured on Potato Dextrose Agar plates and Corn Meal Agar slants, and incubated at 30 and 37°C in the dark to study fungal growth and sporulation respectively [4], [8]. Carbohydrate assimilation tests were performed using freshly prepared yeast nitrogen base (YNB) medium supplemented with sucrose or raffinose, using YNB supplemented with glucose as positive control and YNB without carbohydrates as a negative control. Experiments were performed at least three times on different days and, in the case of discordant results, repeated two additional times. All culture media were from Difco (Becton, Dickinson and Company/Sparks MD, USA). Results were interpreted according to the identification key detailed by Marimon and coworkers [11]. Molecular Identification Genomic DNA was extracted and purified from Sporothrix spp mycelial phase by chloroform/isoamyl alcohol method as described [7]. The gene encoding for the nuclear calmodulin was used for molecular differentiation of the isolates because this locus has a high number of parsimony informative sites, allowing Sporothrix differentiation in several genotypes [18]. For partial sequencing of the nuclear calmodulin (CAL) gene, we used the primers CL1 (5′-GA(GA)T(AT)CAAGGAGGCCTTCTC-3′), and CL2A (5′-TTTTTGCATCATGAGTTGGAC-3′) under previously described conditions [7]. Automated sequencing was done using the Sequencing Platform at PDTIS/FIOCRUZ, Brazil [19]. Sequences from both DNA strands were generated and edited with the Sequencher ver. 4.6 software package (Genes Codes Corporation, USA), followed by alignment with Mega version 4.0.2 software. Our sequences were compared by BLAST (Basic Local Alignment Search Tool) with sequences available from NCBI GenBank (Sporothrix AM 398382.1/AM 398393.1/AM 117444.1/AM 116899.1/AM 116908.1). All phylogenetic analyses were performed as previously described [7], [8]. Nucleotide Sequence Accession Numbers All sequences from isolates included in genotypic analysis were deposited in the GenBank database under accession numbers GU456632, HQ426928 to HQ426962, and KC463890 to KC463903. Statistics Data were processed and analyzed using the SPSS 17.0 software. Frequencies and median values were calculated for each group of this study. Results Patients Of the 50 patients, 16 were male and 34 female, with ages ranging from 9 to 83 years (median = 47). Lesions were located at upper limbs (n = 31, 62%), lower limbs (n = 6, 12%), face (n = 1, 2%), trunk (n = 1, 2%), and more than one segment (n = 11, 22%). Fifteen patients (30%) presented with a fixed cutaneous form, 24 (48%) lymphocutaneous form, 6 (12%) disseminated cutaneous form, and 5 (10%) disseminated (involving internal tissues) sporotrichosis. Additionally, six of these patients also presented with erythema nodosum and four with erythema multiforme. Table 1 summarizes the clinical and mycological information for each patient. 10.1371/journal.pntd.0003094.t001 Table 1 Clinical, epidemiological, and mycological aspects of 50 sporotrichosis cases. Genotypic characterization Strain Cat* Clinical form Erythema Treatment (weeks) Phenotypic identification Final identification Genbank n° References 16490 Yes Lymphocutaneous 13 S. brasiliensis S. brasiliensis AM116899 4 16919 Yes Lymphocutaneous 16 S. brasiliensis S. brasiliensis HQ426930 8 17307 Yes Disseminated Cutaneous 20 S. schenckii S. brasiliensis KC463892 This study 17331 Yes Disseminated Cutaneous 36 S. brasiliensis S. brasiliensis HQ426929 This study 17521 Yes Lymphocutaneous 36 S. brasiliensis S. schenckii KC463901 This study 17585 Yes Fixed 24 S. schenckii S. schenckii KC463902 This study 17786 Yes Lymphocutaneous 36 Sporothrix spp. S. brasiliensis HQ426931 This study 17878 Yes Fixed ENa 12 Sporothrix spp. S. brasiliensis HQ426932 8 24372 No Disseminated 44 (AIDS) S. schenckii S. schenckii KC463903 This study 25011 Yes Fixed EMb 16 S. brasiliensis S. brasiliensis HQ426935 8 25303 No Disseminated 260 (AIDS) S. schenckii S. brasiliensis KC463891 This study 25374 Yes Lymphocutaneous EN Lost S. brasiliensis S. brasiliensis KC463894 This study 25457 Yes Lymphocutaneous Lost S. brasiliensis S. brasiliensis KC463890 This study 25521 Yes Disseminated 20 Sporothrix spp. S. brasiliensis HQ426936 8 25758 Yes Lymphocutaneous 16 S. brasiliensis S. brasiliensis KC463895 This study 26611 Yes Fixed EM 16 (HIV) Sporothrix spp. S. brasiliensis HQ426937 8 26938 Yes Fixed 48 Sporothrix spp. S. brasiliensis HQ426938 8 26945 No Lymphocutaneous 14 Sporothrix spp. S. brasiliensis HQ426939 8 26961 No Fixed 24 S. schenckii S. schenckii JN995605 34 27022 Yes Disseminated Cutaneous 8 S. brasiliensis S. brasiliensis HQ426940 8 27052 No Fixed EN 12 Sporothrix spp. S. brasiliensis HQ426941 8 27087 Yes Lymphocutaneous 64 S. brasiliensis S. brasiliensis HQ426942 8 27100 Yes Fixed 36 S. schenckii S. brasiliensis JN995609 34 27130 Yes Lymphocutaneous 16 Sporothrix spp. S. brasiliensis HQ426943 8 27133 Yes Fixed Lost S. schenckii S. brasiliensis JN995608 34 27177 Yes Lymphocutaneous 6 Sporothrix spp. S. brasiliensis HQ426944 8 27209 Yes Lymphocutaneous 12 Sporothrix spp. S. brasiliensis HQ426946 8 27288 Yes Lymphocutaneous 104 Sporothrix spp. S. brasiliensis HQ426945 8 27372 Yes Fixed EM 12 Sporothrix spp. S. brasiliensis HQ426947 8 27375 Yes Fixed EN SRc S. schenckii S. brasiliensis KC463898 This study 27387 Yes Lymphocutaneous 12 Sporothrix spp. S. brasiliensis HQ426948 8 27417 No Lymphocutaneous 16 Sporothrix spp. S. brasiliensis HQ426949 8 27445 Yes Disseminated Cutaneous SR S. brasiliensis S. brasiliensis HQ426950 8 27454 Yes Lymphocutaneous 22 S. brasiliensis S. brasiliensis KC463896 This study 27558 Yes Fixed 12 S. schenckii S. brasiliensis KC463899 This study 27722 No Fixed SR S. mexicana S. schenckii HQ426961 8 27930 No Lymphocutaneous 10 Sporothrix spp. S. brasiliensis HQ426951 8 28329 Yes Lymphocutaneous 16 S. schenckii S. brasiliensis JN995610 34 28403 Yes Lymphocutaneous 10 Sporothrix spp. S. brasiliensis KC463900 This study 28487 Yes Disseminated Cutaneous EN 16 S. brasiliensis S. brasiliensis HQ426928 8 28604 Yes Lymphocutaneous 10 S. brasiliensis S. brasiliensis HQ426953 8 28665 Yes Fixed SR S. brasiliensis S. brasiliensis JN995606 34 28701 Yes Disseminated Cutaneous 20 Sporothrix spp. S. brasiliensis HQ426954 8 28772 Yes Lymphocutaneous 12 Sporothrix spp. S. brasiliensis HQ426955 8 28790 Yes Lymphocutaneous 4 S. brasiliensis S. brasiliensis HQ426956 8 28988 Yes Lymphocutaneous EM 12 S. schenckii S. brasiliensis KC463897 This study 30650 Yes Disseminated EN 16 S. brasiliensis S. brasiliensis KC463893 This study 33605 Yes Disseminated 34 (AIDS) Sporothrix spp. S. brasiliensis HQ426957 8 33722 Yes Lymphocutaneous 12 Sporothrix spp. S. brasiliensis HQ426958 8 34007 Yes Fixed Lost Sporothrix spp. S. brasiliensis HQ426959 8 *indicates exposure (Yes) or no exposure (No) to cats. a EN: erythema nodosum. b EM : erythema multiforme. c SR: spontaneous regression of lesions. Mycological and Phenotypic Identification Of the 50 strains, 45 (90%) were classified by molecular methods as S. brasiliensis and 5 (10%) as S. schenckii. In 21 (42%) isolates, results from phenotypic tests were inconclusive, precluding species differentiation; these strains were phenotypically classified as Sporothrix spp. Interestingly, phenotypic identification of 10 (20%) isolates did not match to the genotypic results. Eight (16%) strains phenotypically classified as S. schenckii, DNA sequencing clustered them amid S. brasiliensis. The strain phenotypically classified as S. mexicana was genotypically identified as S. schenckii, and one S. brasiliensis was classified as S. schenckii by CAL sequencing. Mycological, Clinical and Epidemiological Data Forty-two (93.3%) of the strains identified taxonomically as S. brasiliensis were from the Rio de Janeiro endemic area of sporotrichosis, including Rio de Janeiro city, Duque de Caxias, Belford Roxo, Sao João de Meriti, Nova Iguaçu, Nilópolis, and Mesquita (Fig. 1). The other three (6.7%) S. brasiliensis strains were isolated from patients who lived in Teresópolis, a county 91 km away from Rio de Janeiro city. S. brasiliensis was isolated from 32 of 34 women (94%). Forty (88.9%) patients with S. brasiliensis had documented contacts with cats. Two additional S. brasiliensis-infected patients (4.4%) reported plant and glass trauma preceding the development of sporotrichosis. 10.1371/journal.pntd.0003094.g001 Figure 1 Map of Rio de Janeiro state, Brazil. Names of the cities of origin of the 50 patients included in this study are indicated. Cities in gray, which comprise the Rio de Janeiro metropolitan area, are related to the zoonotic endemic area of sporotrichosis. With respect to the five patients with S. schenckii, four of them (80%) were isolated from patients who lived in three different rural regions and one urban area (in Itaboraí, Barra do Piraí, Casimiro de Abreu, and Teresópolis, respectively; 45, 100, 127, and 91 km away from Rio de Janeiro city), which are outside of the endemic area. S. schenckii was also isolated from a patient who lived within the zoonotic endemic sporotrichosis area in Rio de Janeiro. Three patients were male and two female. Hypersensitivity reactions such as erythema nodosum or erythema multiforme (10 cases), disseminated cutaneous forms (6 cases), and all but one case of lymphocutaneous sporotrichosis were all attributed to infection with S. brasiliensis. Localized cutaneous forms were observed in patients infected with either S. brasiliensis (n = 12, 26.7%) or S. schenckii (n = 3, 60%). Disseminated disease occurred due to S. schenckii in one patient with AIDS, S. brasiliensis in two patients with AIDS, and S. brasiliensis in one patient without any history of immunosuppression. Finally, there was one case of fixed cutaneous sporotrichosis caused by S. brasiliensis in a HIV infected patient with CD4>200 cells/µL. Response to Therapy Four patients infected with S. brasiliensis were lost to follow-up. The three patients with AIDS and disseminated disease were excluded from analysis since they received amphotericin B as part of their antifungal regimen. Spontaneous regression was observed in one patient infected with S. schenckii (fixed form) and three with S. brasiliensis (two fixed and one disseminated cutaneous forms). The remaining 3 cases of S. schenckii required more than 24 weeks of itraconazole, and two of them required increased doses (200 and 400 mg/day). Most of the 35 patients infected by S. brasiliensis included in this analysis (82.9%) resolved with less than 24 weeks of treatment, regardless of their clinical form. For eight S. brasiliensis-infected patients, up to 400 mg/day itraconazole were necessary for clinical cure. The median time to cure for patients with hypersensitivity reactions was similar to the patients without these manifestations (16 weeks), and their diseases resolved with 100 mg/day of itraconazole. Discussion The clinical presentations of sporotrichosis caused by Sporothrix spp are highly variable and poorly understood. Kong and collaborators [20] have demonstrated that S. schenckii genotypes can be correlated with clinical forms of disease, as mice challenged with S. schenckii isolates from patients with fixed cutaneous, lymphocutaneous or disseminated sporotrichosis developed more severe disease according to the severity of the manifestations in the originating patient. However, they did not define the relationships between genotype and treatment outcome or other unusual manifestations. In the present work, we show the direct association between unusual clinical presentations of human sporotrichosis with infection by S. brasiliensis. Although S. brasiliensis caused typical manifestations of fixed cutaneous and lymphocutaneous sporotrichosis, all 10 patients with hypersensitivity reactions and 6/7 patients with disseminated disease were infected with S. brasiliensis. To the best of our knowledge, this is the first work that demonstrates an association between genotypic identification of Sporothrix species and several clinical aspects of human sporotrichosis. Given the recent changes in the nomenclature and advances in the molecular taxonomy of Sporothrix, it is even more important to understand the clinical implications of these advances [21]. As expected, the majority of our isolates have been identified as S. brasiliensis by DNA analyses. Our group has previously characterized S. brasiliensis in 230 (93.5%) of 246 isolates obtained from this endemic zoonotic transmission area [8]. A study by Marimon and coworkers of 127 Sporothrix strains collected from several parts of the world reported only S. brasiliensis among the tested isolates from Rio de Janeiro [4]. There are also a few reports of S. brasiliensis in Brazilian states other than Rio de Janeiro [10], [22], [23], but, in these states, the frequency of S. brasiliensis appears to be lower than that for the other Sporothrix species, with S. schenckii predominating [22]. As noted above, S. brasiliensis genotype caused typical clinical forms of sporotrichosis (lymphocutaneous and fixed cutaneous). However, except for 1 case of disseminated S. schenckii in a patient with AIDS, all of the unusual clinical forms of sporotrichosis were attributed to infection with S. brasiliensis, including disseminated cutaneous sporotrichosis in the absence of an underlying immunosuppressive condition, mucosal involvement affecting nasal cavity or conjunctiva, and hypersensitivity reactions. Regarding the hypersensitivity manifestations, our finding are consistent with the previously reported cases of erythema nodosum and erythema multiforme associated with zoonotic sporotrichosis [24], [25] due to S. brasiliensis. Recently, Sweet syndrome has also described in 3 patients with sporotrichosis [26], and studies are underway to determine, by calmodulin sequencing, the species involved in these cases. Another interesting finding for disease due to S. brasiliensis is the 32/13 female/male ratio, since there is a predominance of male over female patients with sporotrichosis caused by S. schenckii. This can be explained by the fact that the most affected group in the endemic area of sporotrichosis in Rio de Janeiro are housewives that interact with or take care of S. brasiliensis infected cats [1]. Barros and coworkers [27] studied the effects of itraconaozle treatment on cutaneous sporotrichosis in 645 patients from the Rio de Janeiro epidemic, including 87 patients with erythema nodosum or erythema multiforme. Interestingly, they observed that of the patients with hypersensitivity reactions resolved their disease more rapidly compared with patients without these conditions. Although our current study did not find differences regarding treatment between these groups, we did determine that most patients with hypersensitivity reactions presented with fixed cutaneous sporotrichosis. Hence, we believe that hypersensitivity reactions may indicate a robust host response to the S. brasiliensis yeast cells and play a protective role in sporotrichosis, as observed in coccidioidomycosis [28]. The small number of S. schenckii cases in our study calls our attention to the infection caused by this species in Rio de Janeiro. The majority of these cases occurred in rural counties where inhabitants are engaged in agricultural activities, and, therefore, they have frequent and protracted contact with soil. Moreover, in two of these cases, patients denied cat contact. However, S. schenckii was identified in one case from the endemic zoonotic transmission area. Our results suggest that S. schenckii also circulates, in minor proportions, in this endemic area. New studies with a large number of S. schenckii infected patients are necessary to verify the clinical meaningful of sporotrichosis caused by this species. Several factors could influence the different outcomes of sporotrichosis, such as the size of initial inoculum, the host immune response status, depth of traumatic inoculation and fungal virulence [29]. Virulence studies in a mouse infection model have shown that S. brasiliensis is significantly more lethal and results in higher fungal burdens compared to S. schenckii as well as other examined Sporothrix spp. [30]. This same study concludes that lesional mechanisms could be species-specific, which supports our results. Zoonotic transmission of sporotrichosis by cats results in high Sporothrix inoculums for humans, since these animals have high fungal burdens [31]. In some of the endemic sporotrichosis cases, fungal inoculation is presumably repetitive, due to constant bites and scratches suffered by owners [32]. These factors, coupled with the purported higher virulence of S. brasiliensis [30], could account for the unusual and more severe clinical manifestations observed with this species. Itraconazole is the drug of choice for sporotrichosis treatment [27]. It is interesting to note that, regardless the clinical form, there was a trend toward shorter treatment durations in patients with sporotrichosis caused by S. brasiliensis, (median = 16 weeks) than the cases due to S. schenckii (median = 24 weeks), for our study. Although we are comparing 46 cases of S. brasiliensis to only 4 infections due to S. schenckii, we propose that our finding might have a therapeutic implication. The response of S. brasiliensis to treatment is consistent with the fact that S. brasiliensis is more susceptible to antifungal drugs, such as itraconazole, posaconazole, and ravuconazole, than S. schenckii [33]. Moreover, previous results of our group, which included eight S. brasiliensis from this study, showed that strains from the zoonotic endemic area were highly susceptible to itraconazole [14]. Nevertheless, clinical, randomized studies should be performed to confirm these findings. Since different Sporothrix species appear to be related to distinct clinical manifestations and treatment responses, we propose that speciation should become standard laboratory practice. However, it will require a significant effort to make this recommendation a reality in most clinical laboratories. Phenotypic fungal identification is easier than molecular methods to routinely apply. However, in the present work as well as in a previous study from our team [8] and studies from other groups [10], phenotypic description too often fails to be corroborated by genotypic results. Since the differences between the species of the S. schenckii complex were observed at the molecular level [18], we considered DNA sequencing as the gold standard on species identification for the present study. Unfortunately, at present, DNA sequencing is not a suitable methodology for routine clinical laboratories. We recently described a simple and reliable T3B DNA fingerprinting methodology to identify the S. schenckii species complex at the DNA level [34], making it an alternative identification methodology for clinical microbiology laboratories. Our study intended to perform a molecular analysis of the most peculiar clinical cases that we observed in this epidemic as well as typical cases, and also patients presenting from areas outside the sporotrichosis belt of zoonotic transmission, which corresponds to almost 20% of our stored samples. We have checked the medical data from the other 196 patients and they were very similar to the cases we included here. The small size of genotyped strains is a weakness of this study, but in our opinion, these cases illustrate the association of S. brasiliensis to the unusual presentations of sporotrichosis. Also, molecular genotyping with sequencing of the calmodulin gene is laborious and expensive (at present), with significant financial impact in our severely limited funding situation. In conclusion, we have used molecular analysis to clearly demonstrate that S. brasiliensis is the primary cause of endemic sporotrichosis in Rio de Janeiro state. Moreover, S. brasiliensis causes both classic and unusual manifestations of sporotrichosis, including severe disease in otherwise immunocompetent individuals. We also have documented that local and invasive S. brasiliensis disease responds well to itraconazole therapy, with shorter durations of therapy compared to the patients studied with sporotrichosis caused by S. schenckii. This study adds new information to our knowledge base on S. brasiliensis disease and supports the careful speciation of Sporothrix isolates to guide clinical care. Supporting Information Checklist S1 STROBE checklist. (DOCX) Click here for additional data file.

0 comments Cited 76 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases.

Armando Schubach, Fátima Conceição-Silva, Maria Clara Gutierrez Galhardo … (2004)

Sporotrichosis is the most common subcutaneous mycosis in South America. Classic infection is associated with traumatic inoculation of soil, vegetables, and organic matter contaminated with Sporothrix schenckii. Zoonotic transmission has been described in isolated cases or in small outbreaks. Since 1998, we have been observing an increasing number of cases of sporotrichosis in persons from the city of Rio de Janeiro, Brazil, and surroundings. From 1998 to 2001, 178 cases of culture-proven sporotrichosis had been diagnosed. Female patients predominated, and the median age was 39 years. The most frequent clinical presentation was lymphocutaneous disease. Of the 178 patients, 156 reported domiciliary or professional contact with cats with sporotrichosis, and 97 of these patients had a history of receipt of cat scratch or bite. The patients received itraconazole as first-line treatment. This study suggests that feline transmission of sporotrichosis was associated with a large and long-lasting outbreak of the disease in Rio de Janeiro.

0 comments Cited 73 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Contributors

Hiroshi Shiku: Role: Editor

Journal

Journal ID (nlm-ta): PLoS One

Journal ID (iso-abbrev): PLoS ONE

Journal ID (publisher-id): plos

Journal ID (pmc): plosone

Title: PLoS ONE

Publisher: Public Library of Science (San Francisco, CA USA )

ISSN (Electronic): 1932-6203

Publication date (Electronic): 13 September 2016

Publication date Collection: 2016

Volume: 11

Issue: 9

Electronic Location Identifier: e0162764

Affiliations

[1 ]Laboratório de Imunoparasitologia, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, RJ, Brazil

[2 ]VigiLeish-Serviço de Infectologia, Instituto Nacional de Infectologia Evandro Chagas/FIOCRUZ, Rio de Janeiro, RJ, Brazil

[3 ]Departamento de Otorrinolaringologia-Oftalmologia/Faculdade de Medicina/Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil

Mie University Graduate School of Medicine, JAPAN

Author notes

Competing Interests: The authors have declared that no competing interests exist.

Conceived and designed the experiments: FCS FNM.
Performed the experiments: FNM AOS MIP MRL ECFV CMVR FCS.
Analyzed the data: FNM FCS.
Contributed reagents/materials/analysis tools: FNM AOS FCS.
Wrote the paper: FNM AOS MIP MRL ECFV CMVR FCS.

[¤a]

Current address: Laboratório de Pesquisa em Leishmaniose, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, RJ, Brazil

[¤b]

Current address: Hygiene and Tropical Medicine Institute (IHMT), New University of Lisbon (UNL), Lisbon, Portugal

* E-mail: fconcei@ 123456ioc.fiocruz.br

Article

Publisher ID: PONE-D-16-11488

DOI: 10.1371/journal.pone.0162764

PMC ID: 5021344

PubMed ID: 27622513

SO-VID: c59b43ce-a4a5-4493-b23d-e87509b80707

License:

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

History

Date received : 19 March 2016

Date accepted : 30 August 2016

Page count

Figures: 2, Tables: 3, Pages: 11

Funding

Funded by: IOC-FIOCRUZ

Award Recipient : Fatima Conceição-Silva

Funded by: INI-FIOCRUZ

Award Recipient : Armando O. Schubach

Funded by: PROEP-IOC-CNPq

Award ID: 402557/2011-5

Award Recipient : Fatima Conceição-Silva

Funded by: PAEF-IOC-Fiotec

Award ID: IOC-008-FIO-15

Award Recipient : Fatima Conceição-Silva

Funded by: FAPERJ

Award ID: E26/111.230/2014

Award Recipient : Fatima Conceição-Silva

This work was supported by Instituto Oswaldo Cruz-Fundação Oswaldo Cruz, obtained by FCS; Instituto Nacional de Infectologia Evandro Chagas-Fundação Oswaldo Cruz, obtained by AOS; Programa de Excelência em Pesquisa-Instituto Oswaldo Cruz-Fundação Oswaldo Cruz-Conselho Nacional de Desenvolvimento Científico e Tecnológico (402557/2011-5), obtained by FCS; Ações Estratégicas para o Desenvolvimento e Fortalecimento dos Laboratórios Credenciados e das Áreas de Apoio à Pesquisa do Instituto Oswaldo Cruz-Fundação para o desenvolvimento Científico e Tecnológico em Saúde (IOC-008-FIO-15), obtained by FCS; and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E26/111.230/2014), obtained by FCS. AOS is a recipient of fellowships from CNPq and FAPERJ. CMVR is a recipient of FAPERJ fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Custom metadata

Data Availability All relevant data are within the paper and its Supporting Information file.

Is There Any Difference between the In Situ and Systemic IL-10 and IFN-γ Production when Clinical Forms of Cutaneous Sporotrichosis Are Compared?

Read this article at

Abstract

Related collections

PLOS Climate

Most cited references 38

Immune recognition of Candida albicans beta-glucan by dectin-1.

Sporotrichosis in Rio de Janeiro, Brazil: Sporothrix brasiliensis Is Associated with Atypical Clinical Presentations

Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases.

Author and article information

Contributors

Journal

Affiliations

Author notes

Article

History

Page count

Funding

Categories

Custom metadata

Comments

Comment on this article

Similar content 119

Cited by 4

Most referenced authors 593